In an exclusive interview with Pharma Industrial India, Syed Ahmed, our CEO shares how the company is revolutionizing vaccine manufacturing through automation and digitalization. He discusses how our methodology position us at the forefront of global vaccine manufacturing, enhancing accessibility and accelerating timelines to meet global health demands.
Syed Ahmed, our CEO discusses the company’s innovative approach to solving global healthcare challenges in an exclusive interview with Dun & Bradstreet for the LEAP India Startup Summit. Focusing on our journey from a startup to an internationally recognized player in biopharmaceuticals, he highlights the company’s commitment to leveraging cutting-edge technologies in vaccine development and diagnostics
Our CEO, Syed Ahmed, delves into the company's groundbreaking initiatives in biopharmaceutical manufacturing in an exclusive interview with PharmaBiz magazine. Interviewed by Shardul Nautiyal, the conversation focuses on our strategic efforts to expand global vaccine access through its Global Capability Mapping Collaboration (GCMC). Ahmed emphasizes how GCMC brings together key stakeholders to address gaps in manufacturing capacity and ensures scalable, cost-effective vaccine production.
We thrive to drive innovation in global health with our impactful initiatives. Explore this video to learn more about our pioneering efforts in providing affordable, scalable, and effective healthcare solutions for developing countries. Together, we aim to transform lives and create a healthier world.
We were featured in an exclusive Q&A with the Innovation Council, highlighting its mission to enable vaccine and biotherapeutic manufacturing in low- and middle-income countries (LMICs). The feature explores our three-pronged approach to innovation, impactful collaborations, and commitment to creating sustainable healthcare solutions from "concept to commercialization."
Featured in SAIF Talk for our COVID 19 vaccine and monoclonal antibodies, the writeup highlights our proprietary Pichia pastoris platform for cost-effective, scalable, and adaptable recombinant vaccines and antibodies, offering equitable solutions for low- and middle-income countries. This initiative underscores our commitment to addressing global health challenges with innovative biotechnological advancements.
We have been recognized as one of the Top 10 Best Biotechnology Companies of 2020 for its groundbreaking efforts in enabling affordable and accessible vaccines and biopharmaceuticals for developing nations. With a focus on indigenous R&D and strategic global partnerships, Ww aim to continue to bridge gaps in healthcare equity.
We were featured in Startup City Magazine (December 2019) for our impactful initiatives in enabling access to essential vaccines and biopharmaceuticals in developing nations. Highlighting our innovative approach to healthcare equity, the article explores our journey, mission, and dedication to bring the needed change.
© 2023 TechInvention. Developed by Scivision Solutions Pvt. Ltd.